Transcranial Ultrasound in Clinical SONothrombolysis
Stopped early · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Acute Ischemic Stroke
In brief
This is a randomized, placebo controlled, parallel group dose escalation trial to evaluate the safety, tolerability, and activity of four sequential dose tiers of MRX-801 and ultrasound as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.
Key facts
- Study ID
- NCT00504842
- Run by
- ImaRx Therapeutics
- People needed
- 72
- Starts
- 2006-12-01
- Expected to finish
- 2008-03-01
- Last updated by the study team
- 2008-04-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Acute ischemic stroke
- Occlusion demonstrated by transcranial Doppler ultrasound
- Eligible for tPA
You may not qualify if…
- Right to left cardiac shunt
- Moderate to severe COPD
- Uncontrolled hypertension
Where it is running
- University of Alabama — Birmingham, Alabama, United States
- Barrow Neurology Clinics at St. Joseph's Hospital — Phoenix, Arizona, United States
- Hoag Memorial Hospital — Newport Beach, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- Colorado Neurological Institute — Englewood, Colorado, United States
- Christiana Care Health System — Newark, Delaware, United States
- University of Miami — Miami, Florida, United States
- St. Louis University School of Medicine — St Louis, Missouri, United States
- University of Rochester — Rochester, New York, United States
- Lehigh Valley Hospital — Allentown, Pennsylvania, United States
- Methodist Hospital Neurological Institute — Houston, Texas, United States
- University of Texas — Houston, Texas, United States
- Swedish Medical Center — Seattle, Washington, United States
- Bichat - Claude Bernard University Hospital and Medical School — Paris, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.